Ianthus Capital Holdings Inc

General ticker "ITHUF" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $33.5M

Ianthus Capital Holdings Inc does not follow the US Stock Market performance with the rate: -43.3%.

Estimated limits based on current volatility of 10.1%: low 0.00$, high 0.00$

Factors to consider:

  • Current price 60.0% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.01$, 0.03$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.01$, 0.04$]

Financial Metrics affecting the ITHUF estimates:

  • Negative: Non-GAAP EPS, $ of -0.01 <= 0.10
  • Negative: Operating profit margin, % of -20.36 <= 1.03
  • Negative: Operating cash flow per share per price, % of 1.62 <= 2.35
  • Negative: negative Net income
  • Negative: Inventory ratio change, % of 10.21 > 1.08

Similar symbols

Short-term ITHUF quotes

Long-term ITHUF plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $203.02MM $163.21MM $159.24MM
Operating Expenses $226.80MM $275.67MM $199.95MM
Operating Income $-23.78MM $-112.45MM $-40.71MM
Non-Operating Income $-31.97MM $-326.25MM $-19.21MM
Interest Expense $32.67MM $22.25MM $30.16MM
Income(Loss) $-55.75MM $-438.70MM $-59.92MM
Taxes $21.74MM $10.69MM $16.70MM
Profit(Loss) $-77.49MM $-449.39MM $-76.62MM
Stockholders Equity $-23.64MM $10.99MM $-61.67MM
Inventory $30.45MM $29.80MM $25.38MM
Assets $344.99MM $303.47MM $277.41MM
Operating Cash Flow $16.15MM $-19.50MM $3.02MM
Capital expenditure $20.40MM $7.05MM $6.08MM
Investing Cash Flow $-21.32MM $-4.74MM $-3.63MM
Financing Cash Flow $10.24MM $22.06MM $-0.62MM
Earnings Per Share* $-0.44 $-0.07 $-0.01

* EPS are Split Adjusted, recent splits may be reflected with a delay.